Washington HB2145 aims to protect patient access to discounted medications by preventing drug manufacturers from restricting the 340B drug pricing.

Washington HB2145 seeks to safeguard patient access to affordable medications and health care services by prohibiting drug manufacturers from imposing limitations on the 340B drug pricing program. This program allows certain safety net providers to purchase drugs at reduced prices, enabling them to serve low-income and uninsured populations. The bill also prevents manufacturers from requiring data sharing as a condition for drug acquisition or delivery, unless federal law mandates it.

Washington HB2145 aims to protect patient access to discounted medications by preventing drug manufacturers from restricting the 340B drug pricing.

Washington HB2145 seeks to safeguard patient access to affordable medications and health care services by prohibiting drug manufacturers from imposing limitations on the 340B drug pricing program. This program allows certain safety net providers to purchase drugs at reduced prices, enabling them to serve low-income and uninsured populations. The bill also prevents manufacturers from requiring data sharing as a condition for drug acquisition or delivery, unless federal law mandates it.